Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation
Conclusions
In our population of HD patients with AF, the mortality is very high. OAT is not associated with increased mortality, while antiplatelet drugs are. OAT seems, on the contrary, associated with a better survival; however, it does not decrease the incidence of ischaemic stroke, whereas it increases the incidence of bleeding. Bleeding risk is lower in subjects in whom the INR is kept within the therapeutic range.
Source: Nephrology Dialysis Transplantation - Category: Urology & Nephrology Authors: Genovesi, S., Rossi, E., Gallieni, M., Stella, A., Badiali, F., Conte, F., Pasquali, S., Bertoli, S., Ondei, P., Bonforte, G., Pozzi, C., Rebora, P., Valsecchi, M. G., Santoro, A. Tags: Intra- and Extracorporeal Treatments of Kidney Failure Source Type: research
More News: Atrial Fibrillation | Bleeding | Coumadin | Dialysis | Hemodialysis | Hemorrhagic Stroke | Ischemic Stroke | Kidney Transplant | Kidney Transplantation | Stroke | Thrombosis | Transplants | Urology & Nephrology | Warfarin